Skip to content
10-K

Annual Report

U.S. STEM CELL, INC.

0001185185-21-000990

← back to feed
Filed
Jul 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Rd Expense FY 2020 · Dec 31, 2020 $0
Rd Expense FY 2020 · Dec 31, 2019 $263
Operating Cash Flow FY 2020 · Dec 31, 2019 −$1.21M
Current Liabilities FY 2020 · Dec 31, 2019 $8.75M
Total Liabilities FY 2020 · Dec 31, 2019 $9.57M
Current Assets FY 2020 · Dec 31, 2019 $66.3K
Total Assets FY 2020 · Dec 31, 2019 $89.84K
Sga Expense FY 2020 · Dec 31, 2019 $4.45M
Net Income FY 2020 · Dec 31, 2019 −$3.84M
Operating Income restated FY 2020 · Dec 31, 2019 −$3.42M
Gross Profit restated FY 2020 · Dec 31, 2019 $1.74M
Cost Of Revenue restated FY 2020 · Dec 31, 2019 $1.34M
Revenue FY 2020 · Dec 31, 2019 $3.07M
Cash And Equivalents FY 2020 · Dec 31, 2018 $1.36M
Stockholders Equity FY 2020 · Dec 31, 2018 −$6.88M